Voyageur Pharmaceuticals (CVE:VM) Shares Down 9.5% – Should You Sell?

Shares of Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report) traded down 9.5% during mid-day trading on Thursday . The stock traded as low as C$0.10 and last traded at C$0.10. 167,544 shares changed hands during trading, an increase of 63% from the average session volume of 102,479 shares. The stock had previously closed at C$0.11.

Voyageur Pharmaceuticals Stock Up 11.1 %

The stock’s 50-day moving average price is C$0.07 and its 200-day moving average price is C$0.06. The stock has a market cap of C$13.95 million, a price-to-earnings ratio of -10.00 and a beta of 0.32. The company has a current ratio of 0.17, a quick ratio of 0.84 and a debt-to-equity ratio of 3.21.

Voyageur Pharmaceuticals Company Profile

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

Recommended Stories

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.